← Back to Search

Behavioral Intervention

Gait Therapy for Cerebral Palsy

N/A
Recruiting
Led By Max J Kurz, PhD
Research Sponsored by Father Flanagan's Boys' Home
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Cerebral Palsy diagnosis for Cerebral Palsy participants
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline (cp) and 8 weeks (cp)
Awards & highlights
No Placebo-Only Group

Summary

This trial will study the effects of a therapeutic gait training protocol on adolescents and young adults with cerebral palsy. Blah blah metal in their body will interfere with MRI so they can't do that part of the study. A control group of neurotypical adolescents and young adults will also be assessed.

Who is the study for?
This trial is for adolescents and young adults with cerebral palsy who haven't had orthopedic surgery in the last 6 months and don't have metal implants that would affect MRI scans. Neurotypical individuals without conditions like autism or ADHD can participate as controls.
What is being tested?
The study tests a gait training protocol to improve walking in those with cerebral palsy. It includes brain imaging, neurophysiological tests, mobility assessments, and cognitive tests before and after the therapy.
What are the potential side effects?
While not explicitly stated, potential side effects may include muscle fatigue, discomfort during exercise, or soreness from gait therapy. Brain imaging is non-invasive but may be uncomfortable due to stillness required.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have been diagnosed with Cerebral Palsy.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline (cp) and 8 weeks (cp)
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline (cp) and 8 weeks (cp) for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change in Brain Activity in Sensory Cortices
Change in Hoffmann Reflex
Change in Isolation of Movement
+6 more
Secondary study objectives
Cognitive related changes induced via physical therapy - Caregiver Priorities & Child Health Index of Life with Disabilities (CPCHILD) Questionnaire
Cognitive related changes induced via physical therapy - Child and Adolescent Sleep Checklist (CASC)
Cognitive related changes induced via physical therapy - D2 - Test of Attention
+8 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Cerebral Palsy Youth/Young AdultsExperimental Treatment1 Intervention
Baseline and 8 week assessments; 8 week gait therapy
Group II: Neurotypical Youth/Young AdultsActive Control1 Intervention
No intervention administered. The controls will only undergo initial baseline assessments.

Find a Location

Who is running the clinical trial?

Father Flanagan's Boys' HomeLead Sponsor
12 Previous Clinical Trials
1,458 Total Patients Enrolled
2 Trials studying Cerebral Palsy
114 Patients Enrolled for Cerebral Palsy
Max J Kurz, PhDPrincipal InvestigatorFather Flanagan's Boys' Home
4 Previous Clinical Trials
185 Total Patients Enrolled
3 Trials studying Cerebral Palsy
153 Patients Enrolled for Cerebral Palsy

Media Library

Gait Therapy (Behavioral Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT04360395 — N/A
Cerebral Palsy Research Study Groups: Cerebral Palsy Youth/Young Adults, Neurotypical Youth/Young Adults
Cerebral Palsy Clinical Trial 2023: Gait Therapy Highlights & Side Effects. Trial Name: NCT04360395 — N/A
Gait Therapy (Behavioral Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04360395 — N/A
~11 spots leftby May 2025